Submitted by amarin on Wed, 05/29/2019 - 10:00 Home ID Reference 16896 News title U.S. FDA Grants Priority Review for Vascepa® (Icosapent Ethyl) Supplemental New Drug Application Seeking Cardiovascular Risk Reduction Indication
